Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
Danilo De Gregorio, Jelena Popić, Justine P. Enns, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 5
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 179
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 166
Psychedelics and Other Psychoplastogens for Treating Mental Illness
Maxemiliano V. Vargas, Retsina Meyer, Arabo A. Avanes, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 113
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 113
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 79
Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin
Pasha A. Davoudian, Ling-Xiao Shao, Alex C. Kwan
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 468-480
Open Access | Times Cited: 78
5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 3, pp. 351-358
Open Access | Times Cited: 58
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder
Shilu Deepa Thomas, Niraj Kumar Jha, Shreesh Ojha, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1889-1889
Open Access | Times Cited: 54
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Étienne Billard, Alexandre Torbey, Antonio Inserra, et al.
Cellular Signalling (2025) Vol. 127, pp. 111588-111588
Closed Access | Times Cited: 4
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 67
Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder
Rafael G. dos Santos, Flávia de Lima Osório, Juliana Mendes Rocha, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 5, pp. 540-550
Closed Access | Times Cited: 66
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
Danilo De Gregorio, Antonio Inserra, Justine P. Enns, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 6, pp. 1188-1198
Open Access | Times Cited: 60
Neural basis of prosocial behavior
Ye Emily Wu, Weizhe Hong
Trends in Neurosciences (2022) Vol. 45, Iss. 10, pp. 749-762
Open Access | Times Cited: 56
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 36
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
John H. Krystal, Alfred P. Kaye, Sarah Jefferson, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 30
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
The role of neurotrophic factors in novel, rapid psychiatric treatments
Jihye Kim, Michelle He, Alina K. Widmann, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 227-245
Closed Access | Times Cited: 24
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 13
Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them – A scoping review of available literature
Leonor Miranda
Brain Research (2024) Vol. 1846, pp. 149226-149226
Open Access | Times Cited: 13
Microdosing Psychedelics: Current Evidence From Controlled Studies
Robin J. Murphy, Suresh Muthukumaraswamy, Harriet de Wit
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024) Vol. 9, Iss. 5, pp. 500-511
Open Access | Times Cited: 11
Potential Differences in Psychedelic Actions Based on Biological Sex
Sheida Shadani, Kyna‐Anne Conn, Zane B. Andrews, et al.
Endocrinology (2024) Vol. 165, Iss. 8
Open Access | Times Cited: 9
Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders
Xue Wang, Cong Lin, Xiaohui Wang
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 903-906
Closed Access | Times Cited: 1
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 51
Psychedelics, Sociality, and Human Evolution
José Manuel Rodríguez Arce, Michael Winkelman
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top